Fishers-based The Clarke Companies is expanding its portfolio of life sciences-focused businesses with the acquisition of Covex LLC, an information technologies firm in Pennsylvania.
The company says the acquisition helps it to better serve customers as “FDA regulations drive the convergence of enterprise IT with manufacturing and operations.”
Clarke specializes in automation and packaging for a variety of biopharma and medical device businesses. The acquisition doubles the size of The Clarke Companies and expands its geographic footprint.
“The acquisition of Covex expands Clarke’s midwestern geographic footprint into the Northeast and Southeast’s biopharma and medical device markets and integrates the expertise of both companies for its enterprise customers who require a highly specialized and efficient single-source solution,” says John Duffin, president, The Clarke Companies.
The company says the Covex acquisition was led by private equity sponsor Lightview Capital, which originally invested in Clarke in 2015, and Maranon Capital, which provided debt financing.